Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Sanofi-Aventis S.A. (OP: SNYNF )

97.00 USD +0.21 (+0.22%)
Official Closing Price Updated: 2:19 PM EDT, Oct 23, 2020 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,000
Open 97.00
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 96.79
Today's Range 97.00 - 97.00
52wk Range 77.00 - 108.61
Shares Outstanding 1,249,058,037
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Sanofi Announces $2.5 Million Contribution to Dementia Research
From PR Newswire
FDA Approves Use of Menactra® Vaccine for Booster Immunization Against Potentially Deadly Disease
Approval aligns with Centers for Disease Control and Prevention's recommendations for meningococcal vaccination 
From PR Newswire

Performance

YTD
-3.00%
-3.00%
1 Month
-3.96%
-3.96%
3 Month
-6.73%
-6.73%
6 Month
-5.83%
-5.83%
1 Year
+7.36%
+7.36%

More News

Read More
Bernie Sanders lashed out at a drug company for potentially profiting from Zika (SNYNF)
Tags Bernie Sanders, Drug prices, Vaccines, Pharmaceutical Industry, Sanofi, SNYNF
From Business Insider
Intrexon Announces Exclusive Channel Collaboration with Sanofi to Optimize Production for a Specific Family of Active Pharmaceutical Ingredients
From PR Newswire
Regeneron and Sanofi Announce Presentation of Detailed Positive Results from Four Pivotal Alirocumab Trials at ESC Congress 2014
From PR Newswire
Sanofi and Regeneron Announce Presentation of Detailed Positive Results from Four Pivotal Alirocumab Trials at ESC Congress 2014
From PR Newswire
Regeneron and Sanofi to Present Results from Four Phase 3 Alirocumab Trials in Hot Line Session at ESC Congress 2014
From PR Newswire
Genzyme Announces Launch of “Expression of Hope III” Program to Build Awareness of Lysosomal Storage Disorders Through Works of Art
From Business Wire News Releases
Genzyme to Feature Multiple Sclerosis Pipeline and Present New Data on Aubagio and Lemtrada at ECTRIMS
From Business Wire News Releases
Sanofi Pasteur Announces Publication of Positive Data for Fluzone® High-Dose Vaccine in The New England Journal of Medicine
From PR Newswire
Sanofi Launches Authorized Generic Version of Eloxatin® (oxaliplatin injection)
From PR Newswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.